Retrospective Study of Neonatal Outcomes with the Use of Magnesium Sulfate in Case of Preterm Labor

Abstract

The use of magnesium sulphate for pregnancy toxemia or preterm labor was not widely accepted because the majority of reports over the last decade showed magnesium disturbances in the neonate. However, its use has been increased in order to prevent uterine contractions during preterm labor, and it is now a commonly used tocolytic drug. Recently, a few studies have indicated that the use of magnesium sulfate has a neuroprotective effect on the neonate, but it has some toxic effects when used for an extended period of time. The goal of this study is to assess the neonatal outcomes of preterm births, because it is still unclear how to describe the neonatal outcomes with the use of magnesium sulphate during preterm labor. STUDY DESIGN: Retrospective observational analysis was carried out in 63 neonates to figure out the effects of magnesium sulphate who were prematurely born. The outcomes were obtained and calculated in percentage. RESULTS: Out of 565 pregnancies, 75 were found to be preterm labor cases in which 63 patients were given magnesium sulfate making an incidence of 11.15% as preterm labor and preterm birth. CONCLUSION: The neonatal outcomes with the use of magnesium sulphate were found and shown the morbidity, mortality or complications. Early Admission in NICU promoted to prevent neonatal morbidity and mortality.